Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Nuclear Medicine

Free Subscription 02.03.2026 1 AJNR Am J Neuroradiol 6 Ann Nucl Med 2 Appl Radiat Isot 1 Brain 14 Clin Nucl Med 1 Hum Brain Mapp 2 J Nucl Cardiol 6 J Nucl Med 2 Nucl Med Commun 1 Phys Med Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. VU KV, Otis HG, Brandmaier A, Osborne JR, et al
   [68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker.
   AJNR Am J Neuroradiol. 2026 Feb 23:ajnr.A9260. doi: 10.3174/ajnr.A9260.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

2. ALTUNDAG K
   Points for clear interpretation of AI-assisted 18 F-FDG PET/CT in breast cancer.
   Ann Nucl Med. 2026 Feb 26. doi: 10.1007/s12149-026-02182.
   PubMed        
   
   
3. OZKAN E, Demir B, Seval GC, Araz M, et al
   [(11)C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma.
   Ann Nucl Med. 2026 Feb 25. doi: 10.1007/s12149-026-02180.
   PubMed         Abstract available
   
   
4. MURAO A, Hara K, Oyama S, Ogura A, et al
   Examination of simple artificial intelligence-based analysis of dopamine transporter scintigraphy for supporting a diagnosis of Parkinson's disease.
   Ann Nucl Med. 2026;40:327-335.
   PubMed         Abstract available
   
   
5. TANTIWETCHAYANON K, Matsubara K, Nuntue C, Shibutani T, et al
   Clinical implementation of voxel-based dosimetry using image-based RT-PHITS Monte Carlo simulations for (177)Lu-DOTATATE radionuclide therapy.
   Ann Nucl Med. 2026;40:286-297.
   PubMed         Abstract available
   
   
6. KESSLER L, Settelmeier S, Pabst KM, Telli T, et al
   Quantitative evaluation of (123)I-MIBG imaging in patients with myocarditis: impairment of cardiac neuronal function revisited.
   Ann Nucl Med. 2026;40:202-208.
   PubMed         Abstract available
   
   
7. LANFRANCHI F, Belgioia L, Vita D, Passoni J, et al
   Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis.
   Ann Nucl Med. 2026;40:178-187.
   PubMed         Abstract available
   
   

   
   Appl Radiat Isot

8. YAMAGUCHI H
   Operational redesign of medical supply management for radiopharmaceutical operations in a hospital without an SPD system.
   Appl Radiat Isot. 2026;231:112496.
   PubMed         Abstract available
   
   
9. ALEZZI M, Kotbi O, Hammid G, Fouda A, et al
   Optimization of CT parameters to reduce radiation dose in SPECT/CT bone scans while preserving diagnostic quality.
   Appl Radiat Isot. 2026;231:112524.
   PubMed         Abstract available
   
   

   
   Brain

10. COGSWELL PM, Lundt ES, Therneau TM, Hu M, et al
    Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition.
    Brain. 2026 Feb 25:awag075. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

11. FENG L, Zhang T, Wang H, Zhang W, et al
    Intraoperative Liver Injury Presenting as Recurrent Fever Detected by 18FDG PET/CT.
    Clin Nucl Med. 2026 Feb 9. doi: 10.1097/RLU.0000000000006370.
    PubMed         Abstract available
    
    
12. JIA C, Mao H, Zhang T, Liang M, et al
    Differential Neural Substrates of Freezing of Gait in Cerebral Small Vessel Disease and Parkinson Disease: A Dual-tracer PET Study.
    Clin Nucl Med. 2026 Feb 11. doi: 10.1097/RLU.0000000000006378.
    PubMed         Abstract available
    
    
13. LI W, Shi W, Li X, Sun J, et al
    Comparative Analysis of 18F-FAPI and 18F-FDG PET/CT in Evaluation of Intestinal Lesions and Disease Activity in Ulcerative Colitis.
    Clin Nucl Med. 2026 Feb 11. doi: 10.1097/RLU.0000000000006371.
    PubMed         Abstract available
    
    
14. WANG X, Wang G, Zhou Z, Zhang K, et al
    Prognostic Value of a Semi-Quantitative Score Based on 123I-MIBG SPECT/CT in Pediatric Patients With Stage 4 High-Risk Neuroblastoma After Induction Therapy.
    Clin Nucl Med. 2026 Feb 13. doi: 10.1097/RLU.0000000000006372.
    PubMed         Abstract available
    
    
15. MAN X, Dong C, Dong A, Song X, et al
    FDG PET/CT in a Case of Inflammatory Myofibroblastic Tumor of the Bladder.
    Clin Nucl Med. 2026 Feb 13. doi: 10.1097/RLU.0000000000006381.
    PubMed         Abstract available
    
    
16. ILKNUR AKS, Cincin E, Kirel B, Oztunali C, et al
    A Rare Cause of False-Positive 18F FDG Uptake in Testicular Adrenal Rest Tumors Mimicking Malignancy in a Patient With Congenital Adrenal Hyperplasia: A Complete Metabolic Response on FDG PET/CT Following Treatment.
    Clin Nucl Med. 2026 Feb 16. doi: 10.1097/RLU.0000000000006321.
    PubMed         Abstract available
    
    
17. LIU J, Li X, Zhou R, Shang Q, et al
    Primary Pseudomyogenic Hemangioendothelioma of the Cranium: Findings on FDG-PET/CT.
    Clin Nucl Med. 2026 Feb 20. doi: 10.1097/RLU.0000000000006379.
    PubMed         Abstract available
    
    
18. GUEDJ M, Dufour O, Charafe-Jauffret E, Ewald J, et al
    "Hot Liver" in Hepar Lobatum Carcinomatosum on [ 18 F]FDG PET-CT.
    Clin Nucl Med. 2026 Feb 20. doi: 10.1097/RLU.0000000000006390.
    PubMed         Abstract available
    
    
19. DUPONT AC, Farges M, Chapelle B, Cancel M, et al
    From One Cancer to Two: [(1)(8)F]FES PET/CT Redirected Diagnosis and Therapy in a Metastatic Breast Cancer Patient.
    Clin Nucl Med. 2026 Feb 23. doi: 10.1097/RLU.0000000000006386.
    PubMed         Abstract available
    
    
20. CHENG K, Xu T, Wang P, Chen F, et al
    Comparative 18F-FDG PET/CT and FAP-targeted PET/CT Findings in Parotid Warthin Tumor.
    Clin Nucl Med. 2026 Feb 23. doi: 10.1097/RLU.0000000000006392.
    PubMed         Abstract available
    
    
21. DHARMASHAKTU Y, Rastogi S, Wakankar R, Shamim SA, et al
    18F-FDG PET/CT Demonstrates Significant Response in Anaplastic Thyroid Carcinoma Treated With Combined Immunotherapy and Targeted Therapy.
    Clin Nucl Med. 2026 Feb 25. doi: 10.1097/RLU.0000000000006207.
    PubMed         Abstract available
    
    
22. HUANG JJ, Zhu HY, Cheng Y, Shao D, et al
    PET/CT Features of Granulomatosis With Polyangiitis Mimicking Left Lung and Tracheal Malignancy.
    Clin Nucl Med. 2026 Feb 24. doi: 10.1097/RLU.0000000000006304.
    PubMed         Abstract available
    
    
23. YILMAZ F, Perktas L, Sekmenli T, Karabagli P, et al
    Intestinal Duplication Cyst Mimicking Meckel Diverticulum: The Role of Tc-99m Pertechnetate SPECT-CT in Rapid Diagnosis.
    Clin Nucl Med. 2026 Feb 23. doi: 10.1097/RLU.0000000000006297.
    PubMed         Abstract available
    
    
24. LIU Y, Ma Y, Tian R, Jiang M, et al
    From Widespread Cutaneous to Systemic Nodal Involvement: Serial FDG PET/CT Findings in Follicular Lymphoma.
    Clin Nucl Med. 2026 Feb 26. doi: 10.1097/RLU.0000000000006400.
    PubMed         Abstract available
    
    

    
    Hum Brain Mapp

25. LIU T, Shen Y, Bai Y, Gao S, et al
    Longitudinal Neuroimaging Reveals Divergent Clinical Associations of Glymphatic Dysfunction and Dopaminergic Degeneration in Parkinson's Disease.
    Hum Brain Mapp. 2026;47:e70477.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

26. KERO T, Kvernby S, Eggers KM, Rischpler C, et al
    Evaluation of Gd-DOTA as a marker for myocardial blood flow using (68)Ga-DOTA and (15)O-water PET.
    J Nucl Cardiol. 2026 Feb 23:102671. doi: 10.1016/j.nuclcard.2026.102671.
    PubMed         Abstract available
    
    
27. AKHTER A, Sharmin S, Rahman F, Afrin R, et al
    Looking Beyond the Myocardium: Incidental Detection of Malignant Neoplasm Through Ectopic (18)F-FDG Uptake on Cardiac PET Viability Imaging.
    J Nucl Cardiol. 2026 Feb 24:102676. doi: 10.1016/j.nuclcard.2026.102676.
    PubMed        
    
    

    
    J Nucl Med

28. BIO IDRISSOU M, Aguiar Ferreira C, Comas Rojas H, Lambert Lepesevich LH, et al
    Preclinical Evaluation of [(177)Lu]Lu-ART-101 for Radiopharmaceutical Therapy of Advanced Prostate Cancer.
    J Nucl Med. 2026 Feb 26:jnumed.125.271543. doi: 10.2967/jnumed.125.271543.
    PubMed         Abstract available
    
    
29. KIANI I, Siri MA, Babaei M, Aliasghari MM, et al
    Quantitative PSMA PET Biomarkers for Predicting Response to (177)Lu-PSMA Therapy in Prostate Cancer: A Systematic Review and Meta-analysis.
    J Nucl Med. 2026 Feb 26:jnumed.125.270872. doi: 10.2967/jnumed.125.270872.
    PubMed         Abstract available
    
    
30. LIU Q, Shi T, Gravel P, Sharma A, et al
    Parametric Cardiac Imaging with (18)F-Flutemetamol PET to Evaluate the Impact of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis.
    J Nucl Med. 2026 Feb 26:jnumed.125.270003. doi: 10.2967/jnumed.125.270003.
    PubMed         Abstract available
    
    
31. KARPIJOKI H, Tuisku J, Palonen S, Han C, et al
    Organ-Specific Perfusion Response to Adenosine as Measured Using Total-Body PET.
    J Nucl Med. 2026 Feb 26:jnumed.125.271613. doi: 10.2967/jnumed.125.271613.
    PubMed         Abstract available
    
    
32. BELLINGE JW, Al-Ogali Z, Hofman MS, Bacchi S, et al
    Clinical Correlation No Longer Required: An LLM Practical Use Scenario in PET Reporting.
    J Nucl Med. 2026 Feb 26:jnumed.126.272216. doi: 10.2967/jnumed.126.272216.
    PubMed        
    
    
33. CHAUSSE G, Hou X, Uribe C, Harsini S, et al
    First-in-Human Evaluation of [(68)Ga]Ga-HTK03149, a PSMA-Targeted Tracer for PET Imaging in Prostate Cancer.
    J Nucl Med. 2026 Feb 26:jnumed.123.266357. doi: 10.2967/jnumed.123.266357.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

34. USMANI S, A Burney I, Ahmed N, Al Riyami K, et al
    Radiolabeled fibroblast activation protein inhibitor PET/computed tomography imaging in invasive lobular breast cancer: a narrative review and research agenda.
    Nucl Med Commun. 2026 Feb 25. doi: 10.1097/MNM.0000000000002132.
    PubMed         Abstract available
    
    
35. LENAERTS M, van der Voort L, Smidt ML, van de Weijer T, et al
    The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [18F] fluorodeoxyglucose PET.
    Nucl Med Commun. 2026 Feb 25. doi: 10.1097/MNM.0000000000002133.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

36. YANG H, He W, Zhao X, Li G, et al
    Performance evaluation of S-PET, a compact, LYSO/BGO phoswich detector small animal PET prototype.
    Phys Med Biol. 2026 Feb 26. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum